Trademarkia Logo

Canada

C$
ANAMANTLE HC CREAM & DESIGN
ABANDONED SECTION 36

on 23 Oct 2007

Last Applicant/ Owned by

BRADLEY PHARMACEUTICALS INC. (A DELAWARE CORPORATION)

383 Route 46 WestFairfield, New Jersey 07004-2402

US

Serial Number

1272367 filed on 8th Sept 2005

Correspondent Address

MARKS & CLERK

33 Yonge Street, Suite 300,Toronto,

ONTARIO

CA

M5E1G4

ANAMANTLE HC CREAM & DESIGN

Trademark usage description

medical kit containing an applicator, wipes and an anti-inflammatory anesthetic, and dermatological preparations, namely, an anti-inflammatory anesthe Read More

Vienna Information


27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 10

Series of letters in different dimensionsSuites de lettres présentant des dimensions différentes

27 . 5 . 15

Series of letters separated from one another other than by a single space -- Note: Includes a series of letters separated, for instance, by framing, strokes or varying levels.Suites de lettres détachées les unes des autres autrement que par le seul espace -- Note: Comprend une suite de lettres détachées par exemple par des encadrements, par des traits ou des niveaux différents.

Classification Information


Class [005]
Pharmaceuticals and herbicides


Comment text

CIPO Classification Code

Classification kind code

Nice

Mark Details


Serial Number

1272367

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 6
on 23rd Oct 2007
Abandoned - Section 36
Submitted for opposition 14
on 2th Aug 2007
Default Notice Sent
Submitted for opposition 12
on 17th Jan 2007
Extension of Time
Submitted for opposition 15
on 11th Jul 2006
Correspondence Created
Submitted for opposition 20
on 14th Mar 2006
Examiner's First Report
Submitted for opposition 22
on 10th Mar 2006
Search Recorded
Submitted for opposition 88
on 23rd Jan 2006
Security Interest Placed
Submitted for opposition 31
on 6th Oct 2005
Formalized
Submitted for opposition 1
on 19th Sept 2005
Created
Submitted for opposition 30
on 8th Sept 2005
Filed